Market LIVE
Published markets; coverage varies by country
Product profile · United States

LEQVIO

 ·  Patent Litigation & Settlement History ↓

IngredientINCLISIRAN SODIUM
Application typeNDA
Application214012
Product001
Dosage formSOLUTION
RouteSUBCUTANEOUS
StrengthEQ 284MG BASE/1.5ML (EQ 189MG BASE/ML)
Approval date2021-12-22
Marketing statusPrescription
Status event—
ApplicantNOVARTIS
Product source

Current GenericRadar decision

Year2036
SelectionCANDIDATE
ReviewFINAL
Anchor typePATENT
Anchor date2036-08-25
Patent anchor2036-08-25
Exclusivity anchor2026-12-22
Protection date2036-08-25
First Final ANDA—
Status event—

GNR judgment: CANDIDATE. Reference year: 2036. Anchor type: PATENT. Patent anchor: 2036-08-25. Exclusivity anchor: 2026-12-22. Anchor date: 2036-08-25. Patent tail: no. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
88092922027-05-10DS/DP/U U-4414YNTRUE_DS
English description not available.
———
88092922027-05-10DS/DP/U U-4249YNTRUE_DS
English description not available.
———
88092922027-05-10DS/DP/U U-4413YNTRUE_DS
English description not available.
———
88092922027-05-10ORANGE_BOOK U-4249;U-4413;U-4414YNTRUE_DS
English description not available.
———
82222222027-12-29U U-4413NYU
English description not available.
———
82222222027-12-29U U-4414NYU
English description not available.
———
82222222027-12-29U U-4249NYU
English description not available.
———
82222222027-12-29ORANGE_BOOK U-4249;U-4413;U-4414NYU
English description not available.
———
101319072028-08-24DS/DP/U U-4413YNTRUE_DS
English description not available.
———
101319072028-08-24DS/DP/U U-4249YNTRUE_DS
English description not available.
———
101319072028-08-24DS/DP/U U-4414YNTRUE_DS
English description not available.
———
101319072028-08-24ORANGE_BOOK U-4249;U-4413;U-4414YNTRUE_DS
English description not available.
———
108067912028-12-04DS —YNTRUE_DS
English description not available.
———
108067912028-12-04ORANGE_BOOK —YNTRUE_DS
English description not available.
———
88289562028-12-04DS/DP/U U-4249YNTRUE_DS
English description not available.
———
88289562028-12-04DS/DP/U U-4414YNTRUE_DS
English description not available.
———
88289562028-12-04DS/DP/U U-4413YNTRUE_DS
English description not available.
———
88289562028-12-04ORANGE_BOOK U-4249;U-4413;U-4414YNTRUE_DS
English description not available.
———
93705822028-12-04DS/DP/U U-4249YNTRUE_DS
English description not available.
———
93705822028-12-04DS/DP/U U-4413YNTRUE_DS
English description not available.
———
93705822028-12-04DS/DP/U U-4414YNTRUE_DS
English description not available.
———
93705822028-12-04ORANGE_BOOK U-4249;U-4413;U-4414YNTRUE_DS
English description not available.
———
81060222029-12-12DS/DP/U U-4249YNTRUE_DS
English description not available.
———
81060222029-12-12DS/DP/U U-4413YNTRUE_DS
English description not available.
———
81060222029-12-12DS/DP/U U-4414YNTRUE_DS
English description not available.
———
81060222029-12-12ORANGE_BOOK U-4249;U-4413;U-4414YNTRUE_DS
English description not available.
———
101253692033-12-05DS/DP/U U-4414YNTRUE_DS
English description not available.
———
101253692033-12-05DS/DP/U U-4413YNTRUE_DS
English description not available.
———
101253692033-12-05DS/DP/U U-4249YNTRUE_DS
English description not available.
———
101253692033-12-05ORANGE_BOOK U-4249;U-4413;U-4414YNTRUE_DS
English description not available.
———
124602062034-08-18DS/DP —NYU
English description not available.
———
124602062034-08-18ORANGE_BOOK —NYU
English description not available.
———
108513772036-08-25U U-4414NYU
English description not available.
———
108513772036-08-25U U-4249NYU
English description not available.
———
108513772036-08-25U U-4413NYU
English description not available.
———
108513772036-08-25ORANGE_BOOK U-4249;U-4413;U-4414NYU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2021-12-222026-12-22English description not available.YY2026-12-22—Source
NCE2021-12-222026-12-22English description not available.YY2026-12-22
NCE
Full coverage date: 2026-12-22
Source
I-9852026-02-122029-02-12English description not available.NN——Source
I-9852026-02-122029-02-12English description not available.NN—
NCE
Full coverage date: —
Source
NPP2026-02-122029-02-12English description not available.NN——Source
NPP2026-02-122029-02-12English description not available.NN—
NCE
Full coverage date: —
Source
ODE-5552026-02-122033-02-12English description not available.NN——Source
ODE-5552026-02-122033-02-12English description not available.NN—
NCE
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (15)
TypeDateRoleBasisSource
PATENT2027-05-10HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-12-29HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-08-24HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2029-12-12HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-12-05HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2034-08-18HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-08-25CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2036-08-25CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.